Last Updated: May 6, 2026

AMLODIPINE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Amlodipine, and when can generic versions of Amlodipine launch?

Amlodipine is a drug marketed by Accord Hlthcare Inc, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Aurobindo Pharma, Glenmark Pharms Ltd, Hetero Labs Ltd V, Jubilant Generics, Macleods Pharms Ltd, Micro Labs, Sciegen Pharms, Teva Pharms Usa, Torrent, Zydus Pharms, Amneal, Synthon Pharms, Accord Hlthcare, Alkem, Amneal Pharms Ny, Chartwell Rx, China Resources, Cipla, Corepharma, Epic Pharma Llc, Gedeon Richter Usa, Genpharm, Graviti Pharms, Hikma, Hikma Pharms, Invagen Pharms, Lupin, Mylan, Orbion Pharms, Oxford Pharms, Pharmobedient, Puracap Labs Blu, Puracap Pharm, Sovereign Pharms, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Sun Pharm Industries, Sunshine, Teva, Teva Pharms Inc, Torrent Pharms, Unichem, Watson Labs, Wockhardt, Zydus Pharms Usa, Apotex, Dr Reddys, Neocubes Pharma, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Heritage, Lupin Pharms, Rising, Teva Pharms, Watson Labs Inc, Hetero Labs, Novel Labs Inc, Strides Pharma Intl, and Lupin Ltd. and is included in eighty-eight NDAs.

The generic ingredient in AMLODIPINE is amlodipine besylate; hydrochlorothiazide; valsartan. There are fifty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; valsartan profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for AMLODIPINE?
What are the global sales for AMLODIPINE?
What is Average Wholesale Price for AMLODIPINE?

Summary for AMLODIPINE

US Patents:	0
Applicants:	64
NDAs:	88
Drug Prices:	Drug price information for AMLODIPINE
Drug Sales Revenues:	Drug sales revenues for AMLODIPINE
DailyMed Link:	AMLODIPINE at DailyMed

Drug patent expirations by year for AMLODIPINE

Drug Prices for AMLODIPINE

US Patents and Regulatory Information for AMLODIPINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	078021-003	Jul 17, 2007	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Lupin	AMLODIPINE BESYLATE AND VALSARTAN	amlodipine besylate; valsartan	TABLET;ORAL	090245-003	Mar 30, 2015	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aurobindo Pharma Ltd	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	202239-002	Sep 5, 2012	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	077262-002	Jul 9, 2007		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dr Reddys Labs Inc	AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE	amlodipine besylate; benazepril hydrochloride	CAPSULE;ORAL	077183-003	Apr 15, 2010	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sciegen Pharms	AMLODIPINE AND OLMESARTAN MEDOXOMIL	amlodipine besylate; olmesartan medoxomil	TABLET;ORAL	209010-001	Dec 3, 2018	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for AMLODIPINE

Amlodipine valsartan 5 shelf life?
Is amlodipine an alternative to lipitor for heart conditions?
Can amlodipine be a lipitor substitute?
Can amlodipine be used as a cholesterol lowering substitute for lipitor?
How long after the expiration date can you take amlodipine?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.